ALLR

Market-moving news on Allarity Therapeutics (NASDAQ: ALLR): filings, earnings, deals and other events, from REDFILED.

Allarity is sponsoring a blank-check company seeking a Nasdaq listing.

ALLR

ALLARITY Sponsors $100M SPAC IPO Filed With the SEC

The Phase 2 cancer drug developer is sponsoring Allarity Acquisition Corp., which filed for a $100 million unit IPO on Nasdaq under the symbol ALLNU.

Allarity is sponsoring a blank-check vehicle seeking a Nasdaq listing.

ALLR

ALLARITY Sponsors $100M SPAC IPO Through Wholly-Owned Subsidiary

The clinical-stage cancer drug developer's Allarity Acquisition Corp. filed an S-1 for a $100 million unit IPO, with Allarity holding about 25% as sponsor.